To monitor the impact of ALCAM alteration on the interaction of cancer and mesothelial cells, we performed both ECIS assay (that records the dynamic interaction between tumour and mesothelial cells) and DiI-based assay (measuring pancreatic/gastric tumour-endothelial interaction). The gene discussed is ALCAM; the disease is gastric neoplasm.